WO2024012873 - ASSOCIATING A DESIGNATED USER WITH A MEDICAMENT DELIVERY DEVICE
National phase entry:
Publication Number
WO/2024/012873
Publication Date
18.01.2024
International Application No.
PCT/EP2023/067595
International Filing Date
28.06.2023
Title **
[English]
ASSOCIATING A DESIGNATED USER WITH A MEDICAMENT DELIVERY DEVICE
[French]
ASSOCIATION D'UN UTILISATEUR DÉSIGNÉ À UN DISPOSITIF D'ADMINISTRATION DE MÉDICAMENT
Applicants **
SHL MEDICAL AG
Inventors
HALLSTRÖM, Ola
CARLSSON, Daniel
RENSTAD, Rasmus
Priority Data
22184332.9
12.07.2022
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1994 | |
| EPO | Filing, Examination, Granting | 8141 | |
| Japan | Filing, Examination, Granting | 2138 | |
| South Korea | Filing, Examination, Granting | 1997 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
20,210
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
A method of a receiver (11) of associating a user with a medicament delivery device configured to communicate a medicament delivery event wirelessly with the receiver (11) is provided. The method comprises receiving (S101), during a preregistration phase, a first wireless signal comprising information identifying at least one medicament delivery device (10a-10d) and biometric information identifying a user of said at least one medicament delivery device (10a-10d), receiving (S102) a second wireless signal identifying a medicament delivery device (10a) communicating a medicament delivery event, determining (S103) whether or not the second wireless signal comprises a device identifier received during the preregistration phase, and if so determining (S104) that the medicament delivery device (10a) identified with the received second wireless signal was used by the user identified with the biometric information for causing the medicament delivery event.[French]
L'invention concerne un procédé d'un récepteur (11) pour l'association d'un utilisateur à un dispositif d'administration de médicament configuré pour transmettre sans fil au récepteur (11) un événement d'administration de médicament. Le procédé comprend la réception (S101), pendant une phase de pré-enregistrement, d'un premier signal sans fil comprenant des informations identifiant au moins un dispositif d'administration de médicament (10a à 10d) et des informations biométriques identifiant un utilisateur dudit/desdits dispositif(s) d'administration de médicament (10a à 10d), la réception (S102) d'un second signal sans fil identifiant un dispositif d'administration de médicament (10a) transmettant un événement d'administration de médicament, la détermination (S103) du fait que le second signal sans fil comprend ou non un identifiant de dispositif reçu pendant la phase de pré-enregistrement et, si tel est le cas, la détermination (S104) du fait que le dispositif d'administration de médicament (10a) identifié avec le second signal sans fil reçu a été utilisé par l'utilisateur identifié avec les informations biométriques pour provoquer l'événement d'administration de médicament.